tradingkey.logo
搜尋

Lineage Cell Therapeutics Inc

LCTX
添加自選
1.080USD
-0.020-1.80%
收盤 07-31 16:00美東報價延遲15分鐘
269.24M總市值
虧損本益比TTM

LCTX 財務數據

透過專為投資者打造的一站式數據看板,全面查看 Lineage Cell Therapeutics Inc 的財務狀況。平台將複雜的財務報表整理為可自定義的視圖,助您更輕鬆地進行財務分析。您可以查看最新年度財務報告,也可以通過利潤表、資產負債表和現金流量表,按季度分析公司表現。借助實時財務指標,持續追蹤公司的經營狀況和市場表現更加便捷。

Lineage Cell Therapeutics Inc財報日曆

最新發布
8月 6, 2026
每股收益 / 預測值
--/-0.03
營業收入 / 預測值
--/1.53M
報告期
FY2025 財報
營業收入(YoY)
14.56M
53.24%
每股收益(YoY)
-0.28
-197.00%
分析師評級
BUY
2026/08/02
單季報
單季報+年報
單季報
年報
YOY
隱藏空白列
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
財務指標
每股收益
-7.26%-0.02
126.34%0.00
-709.77%-0.13
-337.27%-0.13
48.81%-0.02
50.04%-0.01
60.48%-0.02
0.46%-0.03
-39.18%-0.04
27.02%-0.03
---0.04
---0.03
---0.03
---0.04
---0.12
----
----
----
----
----
營業收入
14.85%1.73M
130.40%6.61M
-2.59%3.68M
96.38%2.77M
4.02%1.50M
37.36%2.87M
203.29%3.78M
-56.34%1.41M
-39.48%1.44M
9.03%2.09M
-58.44%1.25M
-29.17%3.23M
-54.44%2.39M
63.96%1.92M
32.07%3.00M
789.26%4.55M
1239.39%5.24M
229.01%1.17M
297.55%2.27M
32.64%512.00K
淨利潤
-16.26%-4.81M
126.00%851.00K
-881.58%-29.78M
-428.89%-30.46M
36.73%-4.14M
31.46%-3.27M
57.33%-3.03M
-10.15%-5.76M
-49.63%-6.54M
24.85%-4.78M
-17.15%-7.11M
22.68%-5.23M
38.31%-4.37M
78.08%-6.35M
22.42%-6.07M
-41.25%-6.76M
-400.49%-7.09M
-1526.67%-28.99M
-0.81%-7.82M
26.59%-4.79M
利潤率
-0.65%-277.62%
111.91%13.50%
-917.80%-808.26%
-167.83%-1098.16%
39.26%-275.83%
49.81%-113.32%
86.18%-79.41%
-154.14%-410.01%
-146.05%-454.16%
32.04%-225.77%
---574.48%
---161.33%
---184.58%
---332.22%
---156.33%
----
----
----
----
----
毛利率
2.46%100.00%
4.62%99.00%
0.88%99.86%
1.77%98.59%
4.71%97.60%
7.85%94.63%
14.53%98.99%
0.85%96.88%
-1.89%93.21%
-7.32%87.74%
--86.44%
--96.06%
--95.01%
--94.67%
--95.10%
----
----
----
----
----
資產負債率
-48.51%0.05%
-43.12%0.06%
-33.25%0.09%
-2.67%0.11%
-18.85%0.10%
-23.88%0.11%
-3.12%0.14%
-25.84%0.11%
-27.41%0.12%
45.88%0.14%
--0.14%
--0.15%
--0.16%
--0.10%
--0.03%
----
----
----
----
----
營業收入
14.85%1.73M
130.40%6.61M
-2.59%3.68M
96.38%2.77M
4.02%1.50M
37.36%2.87M
203.29%3.78M
-56.34%1.41M
-39.48%1.44M
9.03%2.09M
-58.44%1.25M
-29.17%3.23M
-54.44%2.39M
63.96%1.92M
32.07%3.00M
789.26%4.55M
1239.39%5.24M
229.01%1.17M
297.55%2.27M
32.64%512.00K
營業利潤
-16.73%-7.59M
-28.14%-6.55M
1.41%-3.79M
15.80%-4.94M
2.34%-6.50M
19.68%-5.11M
42.73%-3.84M
-16.78%-5.87M
-0.29%-6.66M
4.17%-6.36M
-27.69%-6.71M
-18.66%-5.02M
-3.85%-6.64M
76.49%-6.64M
23.26%-5.25M
40.20%-4.23M
9.28%-6.40M
-380.07%-28.24M
-1.75%-6.84M
-10.59%-7.08M
淨利潤
-16.26%-4.81M
126.00%851.00K
-881.58%-29.78M
-428.89%-30.46M
36.73%-4.14M
31.46%-3.27M
57.33%-3.03M
-10.15%-5.76M
-49.63%-6.54M
24.85%-4.78M
-17.15%-7.11M
22.68%-5.23M
38.31%-4.37M
78.08%-6.35M
22.42%-6.07M
-41.25%-6.76M
-400.49%-7.09M
-1526.67%-28.99M
-0.81%-7.82M
26.59%-4.79M
流動資產
12.36%56.16M
16.00%59.16M
22.85%42.26M
8.55%43.84M
9.34%49.98M
32.66%51.00M
-20.88%34.40M
-16.71%40.39M
-7.93%45.72M
-35.93%38.44M
-36.53%43.48M
-34.49%48.49M
-39.35%49.66M
-46.21%60.00M
0.24%68.51M
3.42%74.03M
26.69%81.87M
153.53%111.55M
72.00%68.34M
54.93%71.58M
流動負債總額
-37.75%8.15M
-18.67%11.37M
-32.33%9.38M
-29.58%10.76M
-22.50%13.09M
-22.18%13.98M
-12.70%13.86M
-4.84%15.28M
-1.94%16.89M
-5.38%17.96M
-30.16%15.88M
-36.02%16.05M
-29.96%17.23M
-59.71%18.98M
158.66%22.74M
270.73%25.09M
271.44%24.59M
506.46%47.12M
13.42%8.79M
-9.99%6.77M
總資產
-1.99%109.53M
-0.56%112.58M
-7.20%89.64M
-11.68%90.80M
3.01%111.75M
12.08%113.22M
-9.00%96.59M
-7.96%102.80M
-4.17%108.48M
-18.31%101.02M
-19.06%106.15M
-17.83%111.69M
-21.67%113.20M
-29.15%123.66M
-0.05%131.15M
0.87%135.92M
12.97%144.52M
61.69%174.54M
27.28%131.21M
20.23%134.75M
總負債
66.69%56.84M
91.23%69.24M
116.49%68.84M
21.60%43.69M
-9.06%34.10M
-7.15%36.21M
-19.48%31.80M
-11.14%35.93M
-15.16%37.49M
-24.61%39.00M
-26.31%39.49M
-25.71%40.43M
-25.48%44.19M
-38.16%51.73M
361.11%53.59M
387.97%54.42M
422.12%59.30M
552.37%83.65M
-9.94%11.62M
-22.48%11.15M
總權益
-32.14%52.70M
-43.72%43.35M
-67.90%20.80M
-29.55%47.11M
9.39%77.66M
24.17%77.01M
-2.80%64.79M
-6.15%66.88M
2.86%70.99M
-13.78%62.02M
-14.05%66.66M
-12.57%71.26M
-19.01%69.02M
-20.86%71.94M
-35.15%77.55M
-34.06%81.50M
-26.90%85.22M
-4.45%90.90M
32.61%119.59M
26.52%123.60M
經營淨額
-65.33%-8.08M
23.13%-4.88M
37.52%-3.62M
-7.01%-5.54M
15.51%-4.89M
-5.43%-6.35M
-14.89%-5.79M
17.42%-5.18M
48.56%-5.78M
27.51%-6.02M
8.08%-5.04M
11.24%-6.27M
-151.32%-11.24M
-41.38%-8.30M
-13.04%-5.48M
-30.39%-7.06M
395.04%21.90M
-4.11%-5.87M
-0.02%-4.85M
-27.77%-5.42M
投資淨額
-222.23%-2.33M
-681.94%-15.33M
-100.31%-12.00K
99.84%-14.00K
5107.89%1.90M
-72.95%2.63M
83.22%3.89M
-145.89%-8.79M
-100.25%-38.00K
290.94%9.74M
105.19%2.12M
19851.55%19.16M
33634.78%15.43M
-3394.52%-5.10M
-60067.65%-40.91M
15.65%-97.00K
-100.46%-46.00K
-116.19%-146.00K
-138.20%-68.00K
-101.72%-115.00K
融資淨額
10.25%5.56M
-6.23%20.38M
61233.33%1.83M
-392.38%-307.00K
-64.03%5.04M
167284.62%21.73M
-100.37%-3.00K
-98.13%105.00K
1402000.00%14.02M
-110.66%-13.00K
-16.29%807.00K
16954.55%5.63M
-99.81%1.00K
-87.21%122.00K
-74.08%964.00K
-99.71%33.00K
-97.55%513.00K
-80.18%954.00K
-84.86%3.72M
2145.33%11.29M

常見問題

Lineage Cell Therapeutics Inc的總收入是多少?

根據Lineage Cell Therapeutics Inc的FY2025財報,總收入達到14.56M(同比變化9.50M)。

Lineage Cell Therapeutics Inc的流動資產是多少?

根據Lineage Cell Therapeutics Inc的FY2025財報,流動資產為59.16M(同比變化16.00)。

Lineage Cell Therapeutics Inc的總資產是多少?

根據Lineage Cell Therapeutics Inc的FY2025財報,Lineage Cell Therapeutics Inc的總資產為112.58M(同比變化-0.56)。

Lineage Cell Therapeutics Inc的總負債是多少?

根據Lineage Cell Therapeutics Inc的FY2025財報,Lineage Cell Therapeutics Inc的總責任為69.24M(同比變化91.23)。

Lineage Cell Therapeutics Inc的總權益是多少?

根據Lineage Cell Therapeutics Inc的FY2025財報,Lineage Cell Therapeutics Inc的總權益為43.35M(同比變化-43.72)。

Lineage Cell Therapeutics Inc的淨營業收入是多少?

根據Lineage Cell Therapeutics Inc的FY2025財報,Lineage Cell Therapeutics Inc的淨營業收入為-21.78M(同比變化-1.40)。

Lineage Cell Therapeutics Inc的淨投資是多少?

根據Lineage Cell Therapeutics Inc的FY2025財報,Lineage Cell Therapeutics Inc的淨投資為-13.46M(同比變化-483.06)。

Lineage Cell Therapeutics Inc的淨融資是多少?

根據Lineage Cell Therapeutics Inc的FY2025財報,Lineage Cell Therapeutics Inc的淨融資為26.95M(同比變化-24.84)。

Lineage Cell Therapeutics Inc的每股收益(EPS)是多少?

根據Lineage Cell Therapeutics Inc的FY2025財報,每股收益(EPS)為-0.28(同比變化-197.00)。

Lineage Cell Therapeutics Inc的淨利潤是多少?

根據Lineage Cell Therapeutics Inc的FY2025財報,淨利潤為-63.53M(同比變化-241.41)。

Lineage Cell Therapeutics Inc的淨利潤率是多少?

根據Lineage Cell Therapeutics Inc的FY2025財報,淨利潤率為-435.33(同比變化-122.54)。

Lineage Cell Therapeutics Inc的毛利率是多少?

根據Lineage Cell Therapeutics Inc的FY2025財報,毛利率為99.00(同比變化2.60)。

Lineage Cell Therapeutics Inc的債務與資產比率是多少?

根據Lineage Cell Therapeutics Inc的FY2025財報,債務與資產比率為0.06(同比變化-43.12)。

Lineage Cell Therapeutics Inc的股東權益回報率(ROE)是多少?

根據Lineage Cell Therapeutics Inc的FY2025財報,股東權益回報率(ROE)為-103.36(同比變化-293.82)。

Lineage Cell Therapeutics Inc的資產回報率(ROA)是多少?

根據Lineage Cell Therapeutics Inc的FY2025財報,資產回報率(ROA)為-56.13(同比變化-223.55)。

Lineage Cell Therapeutics Inc的營業利潤是多少?

根據Lineage Cell Therapeutics Inc的FY2025財報,營業利潤為-21.78M(同比變化-1.40)。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有